Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.
Bøhmer
Thomas
T
Bøen
Anne
A
Høymork
Siv Cathrine
SC
D000368:Aged; D000641:Ammonia / Q000097:blood*; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001928:Brain Diseases, Metabolic / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy; D002331:Carnitine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous; D013549:Sweetening Agents / Q000008:administration & dosage; D013831:Thiamine / Q000008:administration & dosage*; D013997:Time Factors; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000008:administration & dosage
D000927:Anticonvulsants; D013549:Sweetening Agents; D014803:Vitamin B Complex; D014635:Valproic Acid; D000641:Ammonia; D005947:Glucose; D002331:Carnitine; D013831:Thiamine